Nitrous oxide

Description

Nitrous oxide, with the chemical name N2O, is a non-flammable gas classified as an oxidizer (5.1). It is recognized by the CAS number 10024-97-2 and is listed in the United States Pharmacopeia (USP).

Uses and Indications

Administration of Nitrous Oxide USP is indicated for use only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of this agent. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrous Oxide USP, which may render its administration contraindicated in certain situations. There are no specific teratogenic or nonteratogenic effects documented for this drug.

Dosage and Administration

Nitrous Oxide is administered via inhalation. The preparation for administration involves ensuring that the strength of Nitrous Oxide is 990 mL in 1 L. Healthcare professionals should ensure proper inhalation techniques are employed to achieve the desired therapeutic effect.

Contraindications

Administration of Nitrous Oxide USP is contraindicated in situations where the practitioner is not licensed or lacks experience in its use and administration. It is essential that the administration is conducted under the supervision of a qualified practitioner who is knowledgeable about the indications, effects, dosages, methods, frequency, duration, hazards, contraindications, side effects, and necessary precautions associated with Nitrous Oxide USP.

Additionally, handling of Nitrous Oxide USP should not occur until all safety precautions have been thoroughly read and understood. Direct inhalation of the gas should be avoided, and contact with eyes, skin, or clothing must be prevented to mitigate potential hazards.

Warnings and Precautions

Administration of Nitrous Oxide USP may pose significant risks and is contraindicated in certain situations. It is imperative that this agent is used solely by or under the supervision of a licensed practitioner who possesses expertise in the administration of Nitrous Oxide USP. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Hazards and Risks Nitrous Oxide USP is classified as an oxidizer and may cause or intensify fire. It is stored under pressure and poses an explosion risk if subjected to heat. Users should be aware that exposure may lead to drowsiness or dizziness, and the gas can displace oxygen, resulting in rapid suffocation. Additionally, contact with the gas may cause frostbite.

General Precautions Prior to handling Nitrous Oxide USP, it is essential that all safety precautions are thoroughly read and understood. The gas should be stored away from clothing and other combustible materials, and care must be taken to keep valves and fittings free from grease and oil. Users should avoid inhaling the gas and prevent contact with eyes, skin, or clothing.

Nitrous Oxide USP should only be used and stored outdoors or in well-ventilated areas. In the event of a fire, efforts should be made to stop the leak if it is safe to do so. A backflow preventative device must be utilized in the piping, and only equipment made from compatible materials and rated for cylinder pressure should be employed. Equipment must also be cleaned for oxygen service prior to use. Valves should be opened slowly, and they must be closed after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is crucial to read and follow the Safety Data Sheet (SDS) before use.

Emergency Instructions In case of feeling unwell, it is advised to contact a poison center or a physician immediately. If Nitrous Oxide USP comes into contact with skin, affected areas should be thawed with lukewarm water without rubbing. Immediate medical advice and attention should be sought in such cases.

Side Effects

Patients receiving Nitrous Oxide may experience a range of adverse reactions, which can vary in seriousness and frequency.

Serious adverse reactions include the potential for drowsiness or dizziness, which may impair the ability to perform tasks requiring mental alertness. Additionally, there is a risk of rapid suffocation due to the displacement of oxygen, which can occur during administration. Frostbite is another serious concern, particularly if the gas is improperly handled or administered.

It is critical to note that Nitrous Oxide is classified as an oxidizer and may cause or intensify fire hazards. Therefore, appropriate precautions must be taken to mitigate these risks.

The administration of Nitrous Oxide USP should only be conducted by or under the supervision of a licensed practitioner who possesses the necessary experience and knowledge regarding its use. This includes understanding the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, and side effects.

Due to the potential for adverse reactions, careful monitoring of patients during and after the administration of Nitrous Oxide is essential to ensure safety and efficacy.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide USP may pose hazards or be contraindicated in pediatric patients. It is essential that this agent is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the potential hazards, contraindications, side effects, and necessary precautions specific to pediatric patients.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The administration of Nitrous Oxide USP may pose potential risks during pregnancy, and its use is considered hazardous or contraindicated in this population. While specific safety concerns regarding the use of Nitrous Oxide during pregnancy are not explicitly detailed in the available data, healthcare professionals should exercise caution when considering its administration to pregnant patients. It is advisable to weigh the potential benefits against the risks to fetal outcomes and to explore alternative analgesic options when necessary. Women of childbearing potential should be informed of these considerations when discussing pain management strategies.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there is no information available concerning the potential for excretion of Nitrous Oxide in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise clinical judgment when considering the use of Nitrous Oxide in patients with compromised liver function, as individual patient factors may influence treatment decisions.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions thoroughly, as this information may be vital for ongoing patient care and for any necessary reporting to regulatory authorities.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: drowsiness, dizziness, and frostbite. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide USP may pose hazards or be contraindicated. It is essential that this substance is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with Nitrous Oxide USP, including its ability to cause or intensify fire, as it is classified as an oxidizer. They should be cautioned that the gas is under pressure and may explode if heated. Additionally, patients should be informed that the use of Nitrous Oxide may lead to drowsiness or dizziness, and that it can displace oxygen, potentially resulting in rapid suffocation. Frostbite is also a risk if the gas comes into contact with skin.

It is crucial for patients to understand that they should not handle Nitrous Oxide until all safety precautions have been read and comprehended. They should be instructed to keep and store the gas away from clothing and other combustible materials, ensuring that valves and fittings remain free from grease and oil. Patients should avoid breathing the gas and should take care to prevent contact with eyes, skin, or clothing. The gas should only be used and stored outdoors or in a well-ventilated area.

In the event of a fire, patients should be advised to stop the leak if it is safe to do so. They should use a backflow preventative device in the piping and ensure that only equipment made of compatible materials and rated for cylinder pressure is utilized. Equipment must be cleaned for oxygen service, and patients should open the valve slowly and close it after each use and when empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). Patients should be encouraged to read and follow the Safety Data Sheet (SDS) prior to use.

In case of an emergency, patients should be informed of the first aid measures to take if Nitrous Oxide is inhaled. They should be removed to fresh air and kept comfortable for breathing, and they should call a poison center or physician if they feel unwell. If the gas comes into contact with skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep and store the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure proper functioning and safety.

For optimal use, the product should only be utilized and stored outdoors or in a well-ventilated area. It is crucial to protect the product from direct sunlight when the ambient temperature exceeds 52°C (125°F) to prevent degradation or potential hazards.

When operating the valve, it should be opened slowly to avoid sudden pressure changes. Additionally, the valve must be closed securely after each use and when the product is empty to maintain safety and integrity.

Additional Clinical Information

The route of administration for the product is via respiratory inhalation. Clinicians should be aware that the administration of Nitrous Oxide USP may pose hazards or contraindications and should only be performed by or under the supervision of a licensed practitioner experienced in its use.

Patient counseling is critical; individuals must read and understand all safety precautions before handling the product. It should be stored away from combustible materials, and precautions should be taken to avoid contact with skin, eyes, or clothing. In case of fire, it is important to stop leaks if safe and to use compatible equipment. First aid measures include removing individuals to fresh air if inhaled and seeking medical attention if adverse effects occur.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Roberts Oxygen Company, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)